Reporting and Contact Us

REPORTING A SAFETY CONCERN

Kyowa Kirin takes patient safety seriously. We routinely monitor information from multiple sources regarding the safety of our products in order to take any necessary actions. If you would like to report a possible side effect of a Kyowa Kirin product, please provide any relevant information you have about the side effect and if possible please include the following information:

1. The initials of the person who experienced the possible side effect and/or other identifiers, such as gender or date of birth
2. The contact information of the person reporting the issue
3. A description of the side effect, such as the signs and symptoms experienced, date the side effect started, and the outcome of the side effect
4. The name of the Kyowa Kirin product and date the person who experienced the side effect began taking it

Please select your country to contact us and/or report a safety concern

Austria

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Bahrain

Follow Up Would you like KKI to Follow up on your recent enquiry?

For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.

Belgium

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Czech Republic
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Denmark

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Estonia

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Finland

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
France

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Germany

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html

Iceland

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html

Ireland

For Ireland, reporting forms and further information can be found at www.hpra.ie . By reporting side effects, you can help provide more information on the safety of medicines. Adverse events should also be reported using the contact form below.

 

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html

Italy

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html

Kuwait

Follow Up Would you like KKI to Follow up on your recent enquiry?

For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.

Latvia

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Lithuania

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Luxembourg

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html

Netherlands

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Norway

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Oman

Follow Up Would you like KKI to Follow up on your recent enquiry?

For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.

Portugal

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Qatar

Follow Up Would you like KKI to Follow up on your recent enquiry?

For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.

Saudi Arabia

Follow Up Would you like KKI to Follow up on your recent enquiry?

For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Saudi Arabia: - The National Pharmacovigilance and Drug Safety Centre (NPC):
Fax: +966-11-205-7662 | SFDA Call Center: 19999
E-mail: npc.drug@sfda.gov.sa
Website: https://ade.sfda.gov.sa/

Spain

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Sweden

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html

Switzerland

Follow Up Would you like KKI to Follow up on your recent enquiry?


We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html

Orders
For orders in the Swiss market, click here.

United Arab Emirates

Follow Up Would you like KKI to Follow up on your recent enquiry?

For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.

United Kingdom

UK Reporting and Contact form

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported using the contact form below.

Follow Up Would you like KKI to Follow up on your recent enquiry?

Adverse events should also be reported to
Kyowa Kirin on +44 (0)1896 664 000

We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html

ADVERSE EVENTS SHOULD BE REPORTED HERE

Click here to search for Kyowa Kirin’s clinical trials

Press & Media
Careers

Reporting
Responsibility

ABOUT US  |  CONTACT US  |  NOTICES  |  TERMS OF USE

MODERN SLAVERY ACT | THIRD PARTY CODE OF CONDUCT

KKI/INT/KKI/0927 September 2024

Copyright © Kyowa Kirin International plc. All rights reserved. This website is developed and funded by Kyowa Kirin International plc.

Kyowa Kirin International plc is a company registered in Scotland (company number SC198780) with registered address at Galabank Business Park, Galashiels TD1 1QH, United Kingdom.

Skip to content